Shanghai Creation Investment (SCI) is a leading investment company that has been at the forefront of the global high-end medical technology industry. With a core philosophy of investing in cutting-edge medical technology, SCI aims to elevate China's healthcare industry. SCI offers a range of services and products to support and transform the medical field.

Their business scope includes direct investment funds (ChuangJun), technology licensing (ChuangKe), and industrial park operation and enterprise landing (ChuangMeng). What sets SCI apart is their expertise in building a sustainable medical industry ecosystem through their unique investment model. They also have a professional incubator alliance that provides specialized incubation and management solutions, along with a state-of-the-art experimental platform for the direct introduction and implementation of leading global medical technologies.

SCI's successful case portfolio showcases their significant contributions to the medical field, including groundbreaking projects such as the world's first one-time-use colonoscopy device developed by Giview and the innovative percutaneous closure device for stroke treatment from Perflow. Partnering with SCI means collaborating with a visionary investment brand that is revolutionizing the medical landscape. Contact them today to learn more about their services and explore potential synergies